載入...
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer
Metastatic breast cancer (MBC) is an extremely recalcitrant disease capable of bypassing current targeted therapies via engagement of several growth promoting pathways. SH2 containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase known to facilitate growth and survival signaling...
Na minha lista:
| 發表在: | Oncogene |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714690/ https://ncbi.nlm.nih.gov/pubmed/33033382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01488-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|